|
1
|
Mentlein R, Hattermann K and Held-Feindt
J: Lost in disruption: Role of proteases in glioma invasion and
progression. Biochim biophys Acta. 1825:178–185. 2012.PubMed/NCBI
|
|
2
|
Mangiola A, Anile C, Pompucci A, Capone G,
Rigante L and De Bonis P: Glioblastoma therapy: Going beyond
Hercules columns. Expert Rev Neurother. 10:507–514. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakada M, Nakada S, Demuth T, Tran NL,
Hoelzinger DB and Berens ME: Molecular targets of glioma invasion.
Cell Mol Life Sci. 64:458–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Westermarck J and Kahari VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEb J.
13:781–792. 1999.PubMed/NCBI
|
|
5
|
Kilian M, Gregor JI, Heukamp I, Hanel M,
Ahlgrimm M, Schimke I, Kristiansen G, Ommer A, Walz MK, Jacobi CA,
et al: Matrix metalloproteinase inhibitor RO 28-2653 decreases
liver metastasis by reduction of MMP-2 and MMP-9 concentration in
BOP-induced ductal pancreatic cancer in Syrian hamsters: Inhibition
of matrix metalloproteinases in pancreatic cancer. Prostaglandins
Leukot Essent Fatty Acids. 75:429–434. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Güllü IH, Kurdoğlu M and Akalin I: The
relation of gelatinase (MMP-2 and -9) expression with distant site
metastasis and tumour aggressiveness in colorectal cancer. Br J
Cancer. 82:2492000.PubMed/NCBI
|
|
7
|
Tsuchiya Y, Endo Y, Sato H, Okada Y, Mai
M, Sasaki T and Seiki M: Expression of type-IV collagenases in
human tumor cell lines that can form liver colonies in chick
embryos. Int J Cancer. 56:46–51. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosenberg RN and Iannaccone ST: The
prevention of neurogenetic disease. Arch Neurol. 52:356–362. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bergers G and Coussens LM: Extrinsic
regulators of epithelial tumor progression: Metalloproteinases.
Curr Opin Genet Dev. 10:120–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ament SM, Gillissen F, Moser A, Maessen
JM, Dirksen CD, von Meyenfeldt MF and van der Weijden T:
Identification of promising strategies to sustain improvements in
hospital practice: A qualitative case study. BMC Health Serv Res.
14:6412014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hong S, Park KK, Magae J, Ando K, Lee TS,
Kwon TK, Kwak JY, Kim CH and Chang YC: Ascochlorin inhibits matrix
metallopro-teinase-9 expression by suppressing activator
protein-1-mediated gene expression through the ERK1/2 signaling
pathway: Inhibitory effects of ascochlorin on the invasion of renal
carcinoma cells. J Biol Chem. 280:25202–25209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho HJ, Kang JH, Kwak JY, Lee TS, Lee IS,
Park NG, Nakajima H, Magae J and Chang YC: Ascofuranone suppresses
PMA-mediated matrix metalloproteinase-9 gene activation through the
Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis.
28:1104–1110. 2007. View Article : Google Scholar
|
|
13
|
Son BH, Ahn SH, KO CD, Ka IW, Gong GY and
Kim JC: Significance of mismatch repair protein expression in the
chemotherapeutic response of sporadic invasive ductal carcinoma of
the breast. Breast J. 10:20–26. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao J, Zhang Y, Ithychanda SS, Tu Y, Chen
K, Qin J and WU C: Migfilin interacts with Src and contributes to
cell-matrix adhesion-mediated survival signaling. J Biol Chem.
284:34308–34320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Melchini A and Traka MH: Biological
profile of erucin: A new promising anticancer agent from
cruciferous vegetables. Toxins (Basel). 2:593–612. 2010. View Article : Google Scholar
|
|
16
|
Cavell BE, Syed Alwi SS, Donlevy AM, Proud
CG and Packham G: Natural product-derived antitumor compound
phenethyl isothiocyanate inhibits mTORC1 activity via TSC2. J Nat
Prod. 75:1051–1057. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim MK and Park JH: Conference on
'Multidisciplinary approaches to nutritional problems'. Symposium
on 'Nutrition and health' Cruciferous vegetable intake and the risk
of human cancer: Epidemiological evidence. Proc Nutr Soc.
68:103–110. 2009. View Article : Google Scholar
|
|
18
|
Fimognari C, Turrini E, Ferruzzi L, Lenzi
M and Hrelia P: Natural isothiocyanates: Genotoxic potential versus
chemoprevention. Mutat Res. 750:107–131. 2012. View Article : Google Scholar
|
|
19
|
Brunelli D, Tavecchio M, Falcioni C,
Frapolli R, Erba E, Iori R, Rollin P, Barillari J, Manzotti C,
Morazzoni P, et al: The isothiocyanate produced from glucomoringin
inhibits NF-κB and reduces myeloma growth in nude mice in vivo.
Biochem Pharmacol. 79:1141–1148. 2010. View Article : Google Scholar
|
|
20
|
Kallifatidis G, Rausch V, Baumann B, Apel
A, Beckermann BM, Groth A, Mattern J, Li Z, Kolb A, Moldenhauer G,
et al: Sulforaphane targets pancreatic tumour-initiating cells by
NF-kappaB-induced antiapoptotic signalling. Gut. 58:949–963. 2009.
View Article : Google Scholar
|
|
21
|
Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS,
Wu SH and Chung JG: Benzyl isothiocyanate (BITC) inhibits migration
and invasion of human colon cancer HT29 cells by inhibiting matrix
metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC
and MAPK signaling pathway. J Agric Food Chem. 58:2935–2942. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang MD, Lai KC, Lai TY, Hsu SC, Kuo CL,
Yu CS, Lin ML, Yang JS, Kuo HM, Wu SH, et al: Phenethyl
isothiocyanate inhibits migration and invasion of human gastric
cancer AGS cells through suppressing MAPK and NF-kappab signal
pathways. Anticancer Res. 30:2135–2143. 2010.PubMed/NCBI
|
|
23
|
Jin CY, Moon DO, Lee JD, Heo MS, Choi YH,
Lee CM, Park YM and Kim GY: Sulforaphane sensitizes tumor necrosis
factor-related apoptosis-inducing ligand-mediated apoptosis through
downregulation of ERK and Akt in lung adenocarcinoma A549 cells.
Carcinogenesis. 28:1058–1066. 2007. View Article : Google Scholar
|
|
24
|
Lee SR, Guo SZ, Scannevin RH, Magliaro BC,
Rhodes KJ, Wang X and Lo EH: Induction of matrix metalloproteinase,
cytokines and chemokines in rat cortical astrocytes exposed to
plasminogen activators. Neurosci Lett. 417:1–5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin CW, Hou WC, Shen SC, Juan SH, Ko CH,
Wang LM and Chen YC: Quercetin inhibition of tumor invasion via
suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9
activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mi L, Gan N and Chung FL: Isothiocyanates
inhibit proteasome activity and proliferation of multiple myeloma
cells. Carcinogenesis. 32:216–223. 2011. View Article : Google Scholar :
|
|
27
|
Hornebeck W, Lambert E, Petitfrère E and
Bernard P: Beneficial and detrimental influences of tissue
inhibitor of metallopro-teinase-1 (TIMP-1) in tumor progression.
Biochimie. 87:377–383. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu WS: The signaling mechanism of ROS in
tumor progression. Cancer Metastasis Rev. 25:695–705. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Woo CW, Lucarelli E and Thiele CJ: NGF
activation of TrkA decreases N-myc expression via MAPK path leading
to a decrease in neuroblastoma cell number. Oncogene. 23:1522–1530.
2004. View Article : Google Scholar
|
|
30
|
Xu HY, Qian AR, Shang P, Xu J, Kong LM,
Bian HJ and Chen ZN: siRNA targeted against HAb18G/CD147 inhibits
MMP-2 secretion, actin and FAK expression in hepatocellular
carcinoma cell line via ERK1/2 pathway. Cancer Lett. 247:336–344.
2007. View Article : Google Scholar
|
|
31
|
Jiménez E, Pérez de la Blanca E, Urso L,
González I, Salas J and Montiel M: Angiotensin II induces MMP 2
activity via FAK/JNK pathway in human endothelial cells. Biochem
Biophys Res Commun. 380:769–774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim SH, Sehrawat A and Singh SV: Dietary
chemopreventative benzyl isothiocyanate inhibits breast cancer stem
cells in vitro and in vivo. Cancer Prev Res (Phila). 6:782–790.
2013. View Article : Google Scholar
|
|
33
|
Chen HJ, Lin CM, Lee CY, Shih NC, Amagaya
S, Lin YC and Yang JS: Phenethyl isothiocyanate suppresses
EGF-stimulated SAS human oral squamous carcinoma cell invasion by
targeting EGF receptor signaling. Int J oncol. 43:629–637.
2013.PubMed/NCBI
|
|
34
|
Annabi B, Rojas-Sutterlin S, Laroche M,
Lachambre MP, Moumdjian R and Béliveau R: The diet-derived
sulforaphane inhibits matrix metalloproteinase-9-activated human
brain microvascular endothelial cell migration and tubulogenesis.
Mol Nutr Food Res. 52:692–700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang TY, Chang WC, Wang MY, Yang YR and
Hsu YC: Effect of sulforaphane on growth inhibition in human brain
malignant glioma GBM 8401 cells by means of mitochondrial- and
MEK/ERK-mediated apoptosis pathway. Cell biochem Biophys.
63:247–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chou YC, Chang MY, Wang MJ, Harnod T, Hung
CH, Lee HT, Shen CC and Chung JG: PEITC induces apoptosis of human
brain glioblastoma GBM8401 cells through the extrinsic- and
intrinsic-signaling pathways. Neurochem Int. 81:32–40. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schnaper HW, Kopp JB, Poncelet AC, Hubchak
SC, Stetler-Stevenson WG, Klotman PE and Kleinman HK: Increased
expression of extracellular matrix proteins and decreased
expression of matrix proteases after serial passage of glomerular
mesangial cells. J Cell Sci. 109:2521–2528. 1996.PubMed/NCBI
|
|
38
|
Nagase H and Woessner JF Jr: Matrix
metalloproteinases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jin Y, Han HC and Lindsey ML: ACE
inhibitors to block MMP-9 activity: New functions for old
inhibitors. J Mol Cell Cardiol. 43:664–666. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen YJ, Wei YY, Chen HT, Fong YC, Hsu CJ,
Tsai CH, Hsu HC, Liu SH and Tang CH: Osteopontin increases
migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK,
ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
J Cell Physiol. 221:98–108. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Velpula KK, Rehman AA, Chelluboina B,
Dasari VR, Gondi CS, Rao JS and Veeravalli KK: Glioma stem cell
invasion through regulation of the interconnected ERK, integrin α6
and N-cadherin signaling pathway. Cell Signal. 24:2076–2084. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Trachootham D, Zhou Y, Zhang H, Demizu Y,
Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, et
al: Selective killing of oncogenically transformed cells through a
ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer
Cell. 10:241–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hsu YC, Chang SJ, Wang MY, Chen YL and
Huang TY: Growth inhibition and apoptosis of neuroblastoma cells
through ROS-independent MEK/ERK activation by sulforaphane. Cell
Biochem Biophys. 66:765–774. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Angel P and Karin M: The role of Jun, Fos
and the AP-1 complex in cell-proliferation and transformation.
Biochim Biophys Acta. 1072:129–157. 1991.PubMed/NCBI
|
|
45
|
Tseng HC, Lee IT, Lin CC, Chi PL, Cheng
SE, Shih RH, Hsiao LD and Yang CM: IL-1β promotes corneal
epithelial cell migration by increasing MMP-9 expression through
NF-κB- and AP-1-dependent pathways. PLoS one. 8:e579552013.
View Article : Google Scholar
|
|
46
|
Reddy KB, Nabha SM and Atanaskova N: Role
of MAP kinase in tumor progression and invasion. Cancer Metastasis
Rev. 22:395–403. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sivaraman VS, Wang H, Nuovo GJ and Malbon
CC: Hyper-expression of mitogen-activated protein kinase in human
breast cancer. J Clin Invest. 99:1478–1483. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen JS, Huang XH, Wang Q, Huang JQ, Zhang
LJ, Chen XL, Lei J and Cheng ZX: Sonic hedgehog signaling pathway
induces cell migration and invasion through focal adhesion
kinase/AKT signaling-mediated activation of matrix
metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar
|
|
49
|
Siesser PM and Hanks SK: The signaling and
biological implications of FAK overexpression in cancer. Clin
Cancer Res. 12:3233–3237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
McLean GW, Avizienyte E and Frame MC:
Focal adhesion kinase as a potential target in oncology. Expert
Opin Pharmacother. 4:227–234. 2003. View Article : Google Scholar : PubMed/NCBI
|
